Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder

ConclusionsResults from this study suggest that depression may be a risk factor for poor CUD treatment outcome and therefore should be addressed in the context of treatment. However, results do not support the use of NAC to concurrently treat co-occurring depressive symptoms and CUD in adults.Trial RegistrationClinicaltrials.gov: NCT01675661
Source: Psychopharmacology - Category: Psychiatry Source Type: research